Glutamate facilitates tumor progression, and suppresses anti-tumor immunity.GLS1 suppresses immune therapy and promote tumor;GLS2 contributes to the p53 tumor suppressionGlutamate in SLC7A11-high cancer prompts immunosuppression. This evidence concerns the gene GLS and neoplasm.